Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.93
Delayed Data
As of Feb 22
 -0.07 / -1.40%
Today’s Change
4.01
Today|||52-Week Range
8.38
+6.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues10.8M13.7M32.0M60.6M
 
 
 
 
 
Cost of Goods Sold495.0K6.6M66.3M25.0M
 
 
 
 
 
Depreciation And Amortization306.0K596.0K1.0M--
 
 
 
 
 
Operating ExpensesGross Income10.0M6.4M-35.3M35.6M
 
 
 
 
 
General Expenses121.3M117.5M113.1M137.3M
 
 
 
 
 
Other Operating Expenses0.000.00-25.6M--
 
 
Research And Development51.4M36.6M29.5M37.7M
 
 
 
 
 
Total Operating Expenses122.1M124.7M154.7M162.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-111.2M-111.1M-122.8M-101.7M
 
 
 
 
 
Extraordinary Charge0.00-1.1M-4.7M--
 
 
 
Interest Expense On Debt--11.4M34.2M--
 
 
 
Other Expenses121.0K0.00-23.0K-62.0M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-110.8M-123.1M-161.0M-163.7M
 
 
 
 
 
Income Taxes-700.0K-90.0K-80.0K-235.0K
 
 
 
 
 
Net Income-111.5M-123.1M-161.1M-163.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS91.0M103.9M105.8M114.5M
 
 
 
 
 
Shares To Calculate EPS Diluted91.0M103.9M105.8M114.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.23-$1.19-$1.52-$1.43
 
 
 
 
 
EPS Diluted-$1.23-$1.19-$1.52-$1.43